Oyen, Willem Jozef Gerard
 Distribuzione geografica
Continente #
NA - Nord America 49.807
AS - Asia 21.718
EU - Europa 5.805
SA - Sud America 2.962
AF - Africa 1.246
Continente sconosciuto - Info sul continente non disponibili 243
OC - Oceania 61
Totale 81.842
Nazione #
US - Stati Uniti d'America 49.079
SG - Singapore 15.640
BR - Brasile 2.486
CN - Cina 2.155
VN - Vietnam 1.974
FI - Finlandia 1.375
IE - Irlanda 1.068
NG - Nigeria 917
FR - Francia 648
DE - Germania 637
IT - Italia 558
HK - Hong Kong 462
CA - Canada 426
GB - Regno Unito 422
NL - Olanda 416
IN - India 264
TR - Turchia 179
BD - Bangladesh 176
AR - Argentina 168
MX - Messico 133
IQ - Iraq 130
RU - Federazione Russa 116
SE - Svezia 114
IL - Israele 106
ZA - Sudafrica 94
PK - Pakistan 91
ES - Italia 72
JP - Giappone 69
PL - Polonia 68
UA - Ucraina 60
CO - Colombia 57
VE - Venezuela 57
CL - Cile 53
EC - Ecuador 53
MA - Marocco 50
ID - Indonesia 48
AU - Australia 46
KE - Kenya 46
UZ - Uzbekistan 45
SA - Arabia Saudita 42
JO - Giordania 34
JM - Giamaica 32
TN - Tunisia 31
AE - Emirati Arabi Uniti 30
EG - Egitto 30
IR - Iran 30
PH - Filippine 30
MY - Malesia 29
PY - Paraguay 29
RO - Romania 28
DZ - Algeria 27
CR - Costa Rica 26
CZ - Repubblica Ceca 24
NP - Nepal 23
AT - Austria 22
AZ - Azerbaigian 22
BO - Bolivia 21
PE - Perù 21
KR - Corea 19
OM - Oman 19
KZ - Kazakistan 17
MD - Moldavia 17
DO - Repubblica Dominicana 16
HN - Honduras 16
LB - Libano 16
BE - Belgio 15
CH - Svizzera 15
UY - Uruguay 15
GR - Grecia 14
LT - Lituania 14
NI - Nicaragua 14
SN - Senegal 14
A2 - ???statistics.table.value.countryCode.A2??? 13
NZ - Nuova Zelanda 13
PA - Panama 13
AL - Albania 12
PT - Portogallo 12
ET - Etiopia 11
PS - Palestinian Territory 11
RS - Serbia 11
GT - Guatemala 10
TT - Trinidad e Tobago 10
DK - Danimarca 9
SV - El Salvador 9
BH - Bahrain 7
BY - Bielorussia 7
HU - Ungheria 7
NO - Norvegia 7
QA - Qatar 7
SY - Repubblica araba siriana 7
BG - Bulgaria 6
HR - Croazia 6
PR - Porto Rico 6
AM - Armenia 5
BB - Barbados 5
CI - Costa d'Avorio 5
XK - ???statistics.table.value.countryCode.XK??? 5
BA - Bosnia-Erzegovina 4
GD - Grenada 4
GE - Georgia 4
Totale 81.536
Città #
Chandler 7.383
Singapore 7.333
Wilmington 6.864
San Mateo 2.586
The Dalles 2.292
Ashburn 1.935
San Jose 1.880
Ann Arbor 1.404
Shanghai 1.383
Helsinki 1.373
Leawood 1.222
Council Bluffs 1.210
Princeton 1.153
Lawrence 1.118
Dublin 1.062
Boardman 1.010
Benin City 911
New York 712
Fairfield 685
Dallas 671
Woodbridge 653
Ho Chi Minh City 638
Paris 577
Hanoi 532
Hong Kong 414
Amsterdam 396
Seattle 389
San Diego 349
Beijing 343
Santa Clara 320
Los Angeles 273
London 248
Toronto 227
São Paulo 224
Milan 206
Phoenix 185
Norwalk 138
Chicago 118
Brooklyn 113
Da Nang 108
Kocaeli 103
Houston 102
Haiphong 88
Rio de Janeiro 85
Falkenstein 80
Atlanta 79
Belo Horizonte 71
Philadelphia 65
Rome 64
Montreal 63
Miami 60
Queens 59
Warsaw 56
Tokyo 55
Buffalo 50
Orem 50
San Francisco 48
Baghdad 47
Johannesburg 46
Boston 45
Las Vegas 45
Brasília 43
Charlotte 43
Dhaka 43
Pune 41
Tashkent 41
Porto Alegre 39
Moscow 38
The Bronx 38
Stockholm 37
Reston 36
Nairobi 35
Mexico City 34
Cleveland 33
Hải Dương 33
Columbus 32
Des Moines 32
Campinas 31
Chennai 31
Hillsboro 31
Monmouth Junction 31
Denver 30
Jacksonville 30
Munich 30
Amman 29
Biên Hòa 29
Curitiba 29
Frankfurt am Main 29
Redmond 29
Milwaukee 28
Washington 28
Riverside 27
Louisville 26
Manchester 26
Minneapolis 26
Abbeville 25
Naples 25
Istanbul 24
Long Beach 24
San Antonio 24
Totale 53.239
Nome #
FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0 219
(18)FDG-PET for staging (non)seminomatous germ cell tumours [(N)SGCT] and for evaluation of postchemotherapy residual masses. 131
Procedure guidelines for PET/CT tumour imaging with Ga-68-DOTA-conjugated peptides: Ga-68-DOTA-TOC, Ga-68-DOTA-NOC, Ga-68-DOTA-TATE 129
18-F fluorodeoxygenase (FDG) positron emission tomography (PET) scanning prior to radical lung radiotherapy. A retrospective audit of practice 129
2-(F-18)-fluoro-2-deoxy-D-glucose positron emission tomography detects clinical relevant adenomas of the colon: A prospective study 125
18F-FDG-PET reduces the number of direct laryngoscopies in patients with suspected recurrent laryngeal carcinoma after radiotherapy 123
Zirconium-89 Labeled Antibodies: A New Tool for Molecular Imaging in Cancer Patients 117
[18F]FDG PET/CT in Large Vessel Vasculitis: The Impact of Expertise and Confounders on Image Analysis 115
[Zr-89]Zr-cetuximab PET/CT as biomarker for cetuximab monotherapy in patients with RAS wild-type advanced colorectal cancer 115
Radiofrequency ablation for autonomously functioning nodules as treatment for hyperthyroidism: subgroup analysis of toxic adenoma and multinodular goitre and predictors for treatment success 111
Abscopal effect of radiotherapy in a patient with metastatic diffuse-type giant cell tumor 110
7TH ANNUAL-MEETING OF THE INTERNATIONAL RESEARCH GROUP IN IMMUNOSCINTIGRAPHY AND IMMUNOTHERAPY 109
F-18-FDG PET/CT for diagnosing infectious complications in patients with severe neutropenia after intensive chemotherapy for haematological malignancy or stem cell transplantation 108
18F-FLT-PET for the evaluation of MEK inhibitor AZD6244 107
Aberrant reward processing in Parkinson's disease is associated with dopamine cell loss 107
F-18-FDG PET/CT for the Detection of Septic Embolisms in Patients with Infectious Endocarditis 107
F-18-FDG PET/CT for Detection of Metastatic Infection in Gram-Positive Bacteremia 104
The Role of FDG-PET in the Assessment of Thyroid Nodules with an Indeterminant or Suspicious Cytologic Diagnosis 104
[F-18]FDG accumulation in an experimental model of multistage progression of cholangiocarcinoma 104
[F-18]-Fluorination of a Leukotriene B4 Receptor Antagonist via Hydrazone Formation and its Application in Infection Imaging 104
3 '-Deoxy-3 '-F-18-Fluorothymidine PET-Derived Proliferative Volume Predicts Overall Survival in High-Grade Glioma Patients 104
F-18-FDG PET, genotype-corrected ACE and sIL-2R in newly diagnosed sarcoidosis 103
18F-FDG PET/CT in Detecting Metastatic Infection in Children 103
[F-18]fluoro-2-deoxy-d-glucose positron emission tomography detects gastric carcinoma in an early stage in an asymptomatic e-cadherin mutation carrier 103
Tumor segmentation and quantitative assessment of glucose metabolism for different histological types of NSCLC using dynamic F-18-FDG PET 103
F-18-FDG PET/CT Optimizes Treatment in Staphylococcus Aureus Bacteremia and Is Associated with Reduced Mortality 103
Kidney protection during peptide receptor radionuclide therapy (PRRT) 102
F-18-FLT PET changes during radiotherapy combined with cetuximab in head and neck squamous cell carcinoma patients 102
A direct comparison of four different Ga-68-labeled RGD peptides for PET/CT imaging of angiogenesis 102
FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0 102
F-18-FDG PET AS A PREDICTOR OF PULMONARY FUNCTION IN SARCOIDOSIS 102
Guideline for PET/CT imaging of neuroendocrine neoplasms with Ga-68-DOTA-conjugated somatostatin receptor targeting peptides and F-18-DOPA 101
Improved selection of patients for hepatic surgery of colorectal liver metastases with FDG-PET: A randomized study 101
Effect of the positron range on the spatial resolution of a new generation pre-clinical PET using fluorine-18, gallium-68, zirconium-89 and iodine-124 101
99mTc-interleukin-8 for imaging acute osteomyelitis 101
Radiation Exposure (Un)Awareness amongst nuclear medicine patients - a systematic review 101
PET-CT for response assessment and treatment adaptation in head and neck cancer 100
EANM/EARL FDG-PET/CT accreditation - summary results from the first 200 accredited imaging systems 100
In-111-Bevacizumab Imaging of Renal Cell Cancer and Evaluation of Neoadjuvant Treatment with the Vascular Endothelial Growth Factor Receptor Inhibitor Sorafenib 100
FDG-PET/CT in radiation treatment planning of head and neck squamous cell carcinoma 99
Background-subtracted optimal threshold segmentation algorithm for FDG-PET based GTV delineation: Theory and experimental validation 99
A 3-step pretargeting strategy to image infection 99
SPECT/CT-based Dosimetry for a Multicentre Trial of Selumetinib Enhanced Radioiodine Treatment of Differentiated Thyroid Cancer: Preliminary Results 98
Imaging of cellular therapies 98
A bivalent leukotriene B-4 antagonist for scintigraphic Imaging of infectious foci 98
In-111-anti-F4/80 for in vivo tracking of tumor associated macrophages 98
F-18-fluorodeoxyglucose positron emission tomography combined with CT in critically ill patients with suspected infection 98
New targeted probes for radioimaging of angiogenesis 97
F-18-FLT PET/CT for Early Response Monitoring and Dose Escalation in Oropharyngeal Tumors 97
Pretargeted immuno-PET imaging and radioimmunotherapy of prostate cancer with an anti-EGP1 x anti-HSG bispecific antibody 97
FDG-PET in diagnosing central venous catheter related infection in stem cell transplant recipients 97
F-18-FDG PET patterns and BAL cell profiles in pulmonary sarcoidosis 97
PET/CT with C-11-choline for evaluation of prostate cancer patients with biochemical recurrence: meta-analysis and critical review of available data 97
Development of Radiotracers for the Determination of the Beta-Cell Mass In Vivo 96
F-18-FDG PET of thyroid nodules with inconclusive cytologic results - Reply 96
Radioimmunotherapy with I-131-cG250 monoclonal antibody in patients with metastasized RCC, a phase I/II study. 96
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer 96
The role of megalin in the renal uptake of radiolabeled peptides 95
Comparison of liver SUV using unenhanced CT versus contrast- enhanced CT for attenuation correction in 18 F-FDGPET/CT 95
FDG-PET and CT in the staging of melanoma patients with lymph node metastases; diagnostic performance and clinical consequences 95
INTERIM ANALYSIS OF A PHASE I RADIOIMMUNOTHERAPY STUDY IN ADVANCED RENAL CELL CARCINOMA PATIENTS USING LUTETIUM-177 LABELED MONOCLONAL ANTIBODY CG250 94
Clinical application of FDG-PET/CT in metastatic infections 94
Ga-68-labelled exendin-3, a new agent for the detection of insulinomas with PET 94
EANM commitment towards involvement and engagement of patients and the public: learning from the UK experience 94
Progress in nuclear medicine procedures in head and neck oncology 93
Zirconium-89-girentuximab PET/CT imaging in renal cell carcinoma: first in man results 93
EANM Focus 1: one small step for two men, one giant leap for a specialty 93
PET and SPECT imaging of rheumatoid arthritis with radiolabeled anti-FAP antibody correlates with severity of arthritis 93
Imaging of Prostate Cancer with Immuno-PET and Immuno-SPECT Using a Radiolabeled Anti-EGP-1 Monoclonal Antibody 93
Megalin Plays an Important Role in the Renal Uptake of Various Radiolabeled Peptides: Studies in Megalin-Deficient Mice 93
Validated image fusion of dedicated PET and CT for external beam radiation therapy in the head and neck area 93
Lesion detection by [Zr-89]Zr-DFO-girentuximab and [F-18]FDG-PET/CT in patients with newly diagnosed metastatic renal cell carcinoma 92
SORAFENIB REDUCES UPTAKE OF 111-INDIUM LABELED BEVACIZUMAB IN CLEAR CELL RENAL CELL CARCINOMA 92
Evaluation of the advanced ReSPECT image reconstruction software in a phantom model and in parathyroid scanning 92
A PHASE IB CLINICAL STUDY WITH 18F-FDG-PET RESPONSE EVALUATION OF THE COMBINATION OF TEMSIROLIMUS (T) AND PEGYLATED LIPOSOMAL DOXORUBICIN (PLD) IN BREAST, ENDOMETRIAL AND OVARIAN CANCER 92
Molecular imaging of hypoxia 91
Practical recommendations for radium-223 treatment of metastatic castration-resistant prostate cancer 91
Albumin derived peptides efficiently reduce renal uptake of radiolabeled peptides 91
Pulmonary sclerosing hemangioma detected by fluorodeoxyglucose positron emission tomography in familial adenomatous polyposis: Report of a case 91
Radiopharmaceuticals to image infection and inflammation 91
Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes 91
F-18-2-Deoxy-2-fluoro-D-glucose Positron Emission Tomography, Computed Tomography, and Magnetic Resonance Imaging for the Detection of Experimental Colorectal Liver Metastases 91
In-111-pentetreotide scintigraphy: procedure guidelines for tumour imaging 90
A modelling approach to estimate the FDG arterial plasma time activity curve in Patlak-based therapy response analysis 90
IMPROVED SELECTION OF PATIENTS FOR HEPATIC SURGERY OF COLORECTAL LIVER METASTASES WITH FDG-PET: RESULTS OF THE RANDOMIZED DUTCH POLEM STUDY 90
Evaluation of a Ga-68-labelled Minigastrin for PET Imaging of CCK2/gastrin Receptor-Positive Tumours 90
Tumor Delineation and Quantitative Assessment of Glucose Metabolic Rate within Histologic Subtypes of Non-Small Cell Lung Cancer by Using Dynamic F-18 Fluorodeoxyglucose PET 90
F-18-FDG PET in detecting metastatic infectious disease 90
F-18-fluorodeoxyglucose positron emission tomography of colonic anastomosis: A possibility to detect anastomotic leakage? A pilot study 90
Update on F-18-fluoro-deoxy-glucose-PET/computed tomography in nonsmall cell lung cancer 89
PET/CT imaging of angiogenesis in head and neck squamous cell carcinoma patients 89
Incidental finding of malignancy in patients preoperatively evaluated for aneurysm wall pathology using PET/CT 89
Dynamic FDG PET in liver metastases of colorectal cancer: repeatability of dynamic and static FDG PET parameters. 89
Spatial resolution of the Inveon small-animal PET scanner for the entire field of view 89
WHICH FACTORS PREDICT THE RESULTS OF PITUITARY SURGERY IN ACROMEGALY 89
Personalised PET imaging in oncology: an umbrella review of meta-analyses to guide the appropriate radiopharmaceutical choice and indication 88
F-18-FDG PET/CT in Local Ablative Therapies: A Systematic Review 88
CAN FOG-PET PREDICT RADIATION TREATMENT OUTCOME IN HEAD AND NECK CANCER? 88
Radioimmunotheapy with [I-131]cG250 in patients with metastasized renal cell cancer: Dosimetric analysis and immunologic response 88
STERICALLY STABILIZED LIPOSOMES LABELED WITH IN-111 TO IMAGE FOCAL INFECTION 88
Totale 9.986
Categoria #
all - tutte 591.554
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 591.554


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.434 0 0 0 1.389 3 6 125 846 434 329 1.015 287
2022/202317.903 2.481 628 1.666 1.827 1.928 1.633 9 1.746 3.329 1.396 999 261
2023/20246.755 651 912 1.757 185 208 613 138 381 91 69 490 1.260
2024/20259.716 186 155 58 29 29 1.005 486 1.576 1.297 2.812 936 1.147
2025/202621.791 3.861 1.005 381 1.706 576 757 9.033 1.435 1.268 975 229 565
2026/20278.875 631 2.790 4.278 1.176 0 0 0 0 0 0 0 0
Totale 81.842